Assetmark, Inc Qiagen N.V. Transaction History

Assetmark, Inc

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$35.55 - $43.57 $391 - $479	11 New	11 $0
Q1 2023 May 05, 2023	BUY	$45.29 - $50.76 $11,096 - $12,436	245 Added 41.6%	834 $38,000
Q4 2022 Feb 10, 2023	BUY	$41.91 - $50.48 $6,915 - $8,329	165 Added 38.92%	589 $29,000
Q3 2022 Nov 01, 2022	SELL	$40.9 - $50.42 $1,717 - $2,117	-42 Reduced 9.01%	424 $18,000
Q2 2022 Aug 03, 2022	BUY	$42.98 - $49.77 $5,802 - $6,718	135 Added 40.79%	466 $22,000
Q1 2022 May 13, 2022	BUY	$42.23 - $54.3 $13,978 - $17,973	331 New	331 $16,000
Q4 2018 Feb 13, 2019	SELL	$32.65 - $37.95 $33,172 - $38,557	-1,016 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$35.99 - $39.39 $2,555 - $2,796	-71 Reduced 6.53%	1,016 $38,000
Q2 2018 Aug 01, 2018	SELL	$31.23 - $37.47 $4,434 - $5,320	-142 Reduced 11.55%	1,087 $39,000
Q1 2018 May 16, 2018	SELL	$31.01 - $34.72 $8,248 - $9,235	-266 Reduced 17.79%	1,229 $40,000
Q4 2017 Feb 13, 2018	SELL	$30.68 - $35.37 $582 - $672	-19 Reduced 1.25%	1,495 $46,000
Q3 2017 Nov 08, 2017	SELL	$31.02 - $32.94 $3,815 - $4,051	-123 Reduced 7.51%	1,514 $48,000
Q2 2017 Aug 15, 2017	SELL	N/A	-12 Reduced 0.73%	1,637 $55,000
Q1 2017 Sep 15, 2017	BUY	N/A	1,649	1,649 $48,000

6.37M

Ticker QGEN
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 227,694,000
Market Cap $10.5B
Description
QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

Stay updated on Assetmark, Inc with notifications on news.